MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma

被引:12
|
作者
Olarte, Irma [1 ]
Martinez, Adolfo [1 ]
Ramos-Penafiel, Christian [1 ]
Castellanos-Sinco, Humberto [1 ]
Zamora, Jorge [1 ]
Collazo-Jaloma, Juan [1 ]
Gutierrez, Mario [1 ]
Gutierrez-Kobeh, Laila [2 ]
Chavez-Olmos, Pedro [3 ]
Manzanilla, Hugo [4 ]
Garrido-Guerrero, Efrain [3 ]
Ordonez-Razo, Rosa M. [5 ]
Miranda, Enrique I. [1 ,6 ]
机构
[1] Hosp Gen Mexico City, Serv Hematol, Lab Biol Mol, Mexico City 06726, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Sch Med, Mexico City, DF, Mexico
[3] CINVESTAV IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico
[4] Hosp Gen Mexico City, Serv Urol, Mexico City 06726, DF, Mexico
[5] IMSS, Ctr Med Siglo 21, Hosp Pediat, Unidad Invest Med Genet Humana, Mexico City, DF, Mexico
[6] Westhill Univ, Sch Med, Mexico City, DF, Mexico
关键词
MAGE-A3; Expression; Prognostic; DLBCL; Lymphoma; NON-HODGKINS-LYMPHOMA; TISSUE MICROARRAY; GENE-EXPRESSION; CANCER; CHEMOTHERAPY; PREDICTION; CARCINOMA; SURVIVAL; MYELOMA; ANTIGEN;
D O I
10.1179/102453311X13085644680384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study evaluates the prognostic value of MAGE-A3 expression in 28 diffuse large B-cell lymphoma (DLBCL) patients. A significant association was observed between MAGE-A3 expressions, assessed by quantitative real-time RT-polymerase chain reaction (PCR), with advanced stages of disease (P<0.05). Elevated serum lactate dehydrogenase (LDH) levels and International Prognostic Index (IPI) score were significantly higher in MAGE-A3-positive patients (P=0.025 and P=0.004, respectively). Expression of MAGE-A3 was associated with poor response to treatment and a significantly shorter overall survival (P<0.001). Our data address new information in the association of MAGE-A3 expression and poor prognosis in DLBCL patients.
引用
收藏
页码:368 / 372
页数:5
相关论文
共 50 条
  • [31] Diffuse large B-cell lymphoma
    Li, Shaoying
    Young, Ken H.
    Medeiros, L. Jeffrey
    PATHOLOGY, 2018, 50 (01) : 74 - 87
  • [32] Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma
    Morales, Domingo
    Beltran, Brady
    De Mendoza, Fernando Hurtado
    Riva, Luis
    Yabar, Alejandro
    Quinones, Pilar
    Butera, James N.
    Castillo, Jorge
    LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 66 - 72
  • [33] Angiomirs expression profiling in diffuse large B-Cell lymphoma
    Borges, Natalia M.
    do Vale Elias, Marcela
    Fook-Alves, Veruska L.
    Andrade, Tathiana A.
    de Conti, Marina Lourenco
    Macedo, Mariana Petaccia
    Begnami, Maria Dirlei
    Campos, Antonio Hugo J. F. M.
    Etto, Leina Yukari
    Bortoluzzo, Adriana Bruscato
    Alves, Antonio C.
    Young, Ken H.
    Colleoni, Gisele W. B.
    ONCOTARGET, 2016, 7 (04) : 4806 - 4816
  • [34] Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma
    Han, Xiao
    Ruan, Jing
    Zhang, Wei
    Zhou, Daobin
    Xu, Dongsheng
    Pei, Qiang
    Ouyang, Mingqi
    Zuo, Mengxuan
    ONCOTARGET, 2017, 8 (29) : 47790 - 47800
  • [35] The Prognostic Value of Skp2 Expression in Egyptian Diffuse Large B-Cell Lymphoma
    Abdou, Asmaa Gaber
    Asaad, Nancy Youssef
    Abd El-Wahed, Moshira Mohammed
    Samaka, Rehab Monir
    Allah, Marwa Salah Gad
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (01): : 47 - 55
  • [36] CD38 expression is an important prognostic marker in diffuse large B-cell lymphoma
    Wada, Fumiya
    Shimomura, Yoshimitsu
    Yabushita, Tomohiro
    Yamashita, Daisuke
    Ohno, Aya
    Imoto, Hiroharu
    Maruoka, Hayato
    Hara, Shigeo
    Ishikawa, Takayuki
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (04) : 483 - 489
  • [37] Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data
    Li, Chenglong
    Zhu, Biao
    Chen, Jiao
    Huang, Xiaobing
    ONCOTARGETS AND THERAPY, 2015, 8 : 3407 - 3413
  • [38] Prognostic Value of Platelet Count in Diffuse Large B-Cell Lymphoma
    Chen, Ling-Ping
    Lin, Shyh-Jer
    Yu, Ming-Sun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (01) : 32 - 37
  • [39] Identification of miR-451 target genes as prognostic markers in diffuse large B-cell lymphoma
    Zhang, Yi
    Wei, Zichen
    Xu, Han
    Wang, Xin
    Gu, Ting
    Dong, Hongliang
    Chang, Hongzhuan
    Pang, Lei
    EXPERT REVIEW OF HEMATOLOGY, 2024,
  • [40] A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil
    Tanaka, Paula Yurie
    Pracchia, Luis Fernando
    Bellesso, Marcelo
    Fischer Chamone, Dalton Alencar
    Calore, Edenilson Eduardo
    Pereira, Juliana
    ANNALS OF HEMATOLOGY, 2010, 89 (01) : 45 - 51